Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

Genetic dynamics underlying cancer progression are largely unknown and several genes involved in highly prevalent illnesses (e.g., hypertension, obesity, and diabetes) strongly concur to cancer phenotype heterogeneity. To study genotype-phenotype relationships contributing to the mutational evolutio...

Full description

Bibliographic Details
Main Authors: Alessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, Gerardo Botti, Angela Lombardi, Jerome Galon, Amalia Luce, Luigi D’Amore, Francesco Perri, Mariachiara Santorsola, Fabienne Hermitte, Giovanni Savarese, Fabiana Tatangelo, Vincenza Granata, Francesco Izzo, Andrea Belli, Stefania Scala, Paolo Delrio, Luisa Circelli, Guglielmo Nasti
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3073
_version_ 1797550275871899648
author Alessandro Ottaiano
Michele Caraglia
Annabella Di Mauro
Gerardo Botti
Angela Lombardi
Jerome Galon
Amalia Luce
Luigi D’Amore
Francesco Perri
Mariachiara Santorsola
Fabienne Hermitte
Giovanni Savarese
Fabiana Tatangelo
Vincenza Granata
Francesco Izzo
Andrea Belli
Stefania Scala
Paolo Delrio
Luisa Circelli
Guglielmo Nasti
author_facet Alessandro Ottaiano
Michele Caraglia
Annabella Di Mauro
Gerardo Botti
Angela Lombardi
Jerome Galon
Amalia Luce
Luigi D’Amore
Francesco Perri
Mariachiara Santorsola
Fabienne Hermitte
Giovanni Savarese
Fabiana Tatangelo
Vincenza Granata
Francesco Izzo
Andrea Belli
Stefania Scala
Paolo Delrio
Luisa Circelli
Guglielmo Nasti
author_sort Alessandro Ottaiano
collection DOAJ
description Genetic dynamics underlying cancer progression are largely unknown and several genes involved in highly prevalent illnesses (e.g., hypertension, obesity, and diabetes) strongly concur to cancer phenotype heterogeneity. To study genotype-phenotype relationships contributing to the mutational evolution of colorectal cancer (CRC) with a focus on liver metastases, we performed genome profiling on tumor tissues of CRC patients with liver metastatic disease and no co-morbidities. We studied 523 cancer-related genes and tumor-immune microenvironment characteristics in primary and matched metastatic tissues. We observed a loss of <i>KRAS</i> and <i>SMAD4</i> alterations and a high granzyme-B+ T-cell infiltration when the disease did not progress. Conversely, gain in <i>KRAS</i>, <i>PIK3CA</i> and <i>SMAD4</i> alterations and scarce granzyme-B+ T-cells infiltration were observed when the tumor evolved towards a poly-metastatic spread. These findings provide novel insights into the identification of tumor oligo-metastatic status, indicating that some genes are on a boundary line between these two clinical settings (oligo- vs. poly-metastatic CRC). We speculate that the identification of these genes and modification of their evolution could be a new approach for anti-cancer therapeutic strategies.
first_indexed 2024-03-10T15:27:01Z
format Article
id doaj.art-d7aad3cbf8f04c7ea6c7e22d9c473189
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:27:01Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d7aad3cbf8f04c7ea6c7e22d9c4731892023-11-20T17:58:26ZengMDPI AGCancers2072-66942020-10-011210307310.3390/cancers12103073Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal CancerAlessandro Ottaiano0Michele Caraglia1Annabella Di Mauro2Gerardo Botti3Angela Lombardi4Jerome Galon5Amalia Luce6Luigi D’Amore7Francesco Perri8Mariachiara Santorsola9Fabienne Hermitte10Giovanni Savarese11Fabiana Tatangelo12Vincenza Granata13Francesco Izzo14Andrea Belli15Stefania Scala16Paolo Delrio17Luisa Circelli18Guglielmo Nasti19Department of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Cancers, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyDepartment of Precision Medicine, University of Campania “L. Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, ItalyDepartment of Pathology, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyDepartment of Pathology, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyDepartment of Precision Medicine, University of Campania “L. Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, ItalyINSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Centre de Recherche des Cordeliers, F-75006 Paris, FranceDepartment of Precision Medicine, University of Campania “L. Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, ItalyAMES-Centro Polidiagnostico Strumentale, Srl, 80013 Naples, ItalyHead and Neck Cancer Medical Oncology Unit, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyDepartment of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Cancers, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyHalioDx, 13288 Marseille, FranceAMES-Centro Polidiagnostico Strumentale, Srl, 80013 Naples, ItalyDepartment of Pathology, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyDepartment of Radiology, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyHepatic Surgery Unit, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyHepatic Surgery Unit, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyFunctional Genomics, Istituto Nazionale Tumori, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyColorectal Abdominal Surgery Division, Istituto Nazionale Tumori, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyAMES-Centro Polidiagnostico Strumentale, Srl, 80013 Naples, ItalyDepartment of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Cancers, Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via M. Semmola, 80131 Naples, ItalyGenetic dynamics underlying cancer progression are largely unknown and several genes involved in highly prevalent illnesses (e.g., hypertension, obesity, and diabetes) strongly concur to cancer phenotype heterogeneity. To study genotype-phenotype relationships contributing to the mutational evolution of colorectal cancer (CRC) with a focus on liver metastases, we performed genome profiling on tumor tissues of CRC patients with liver metastatic disease and no co-morbidities. We studied 523 cancer-related genes and tumor-immune microenvironment characteristics in primary and matched metastatic tissues. We observed a loss of <i>KRAS</i> and <i>SMAD4</i> alterations and a high granzyme-B+ T-cell infiltration when the disease did not progress. Conversely, gain in <i>KRAS</i>, <i>PIK3CA</i> and <i>SMAD4</i> alterations and scarce granzyme-B+ T-cells infiltration were observed when the tumor evolved towards a poly-metastatic spread. These findings provide novel insights into the identification of tumor oligo-metastatic status, indicating that some genes are on a boundary line between these two clinical settings (oligo- vs. poly-metastatic CRC). We speculate that the identification of these genes and modification of their evolution could be a new approach for anti-cancer therapeutic strategies.https://www.mdpi.com/2072-6694/12/10/3073colorectal cancerliver metastasesnext generation sequencing<i>KRAS</i><i>SMAD4</i>
spellingShingle Alessandro Ottaiano
Michele Caraglia
Annabella Di Mauro
Gerardo Botti
Angela Lombardi
Jerome Galon
Amalia Luce
Luigi D’Amore
Francesco Perri
Mariachiara Santorsola
Fabienne Hermitte
Giovanni Savarese
Fabiana Tatangelo
Vincenza Granata
Francesco Izzo
Andrea Belli
Stefania Scala
Paolo Delrio
Luisa Circelli
Guglielmo Nasti
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
Cancers
colorectal cancer
liver metastases
next generation sequencing
<i>KRAS</i>
<i>SMAD4</i>
title Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
title_full Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
title_fullStr Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
title_full_unstemmed Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
title_short Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
title_sort evolution of mutational landscape and tumor immune microenvironment in liver oligo metastatic colorectal cancer
topic colorectal cancer
liver metastases
next generation sequencing
<i>KRAS</i>
<i>SMAD4</i>
url https://www.mdpi.com/2072-6694/12/10/3073
work_keys_str_mv AT alessandroottaiano evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT michelecaraglia evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT annabelladimauro evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT gerardobotti evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT angelalombardi evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT jeromegalon evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT amalialuce evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT luigidamore evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT francescoperri evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT mariachiarasantorsola evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT fabiennehermitte evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT giovannisavarese evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT fabianatatangelo evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT vincenzagranata evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT francescoizzo evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT andreabelli evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT stefaniascala evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT paolodelrio evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT luisacircelli evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer
AT guglielmonasti evolutionofmutationallandscapeandtumorimmunemicroenvironmentinliveroligometastaticcolorectalcancer